Skip to main navigation Skip to search Skip to main content

A Phase 2, Randomized, Parallel, Open-Label Comparator-Controlled Trial to Evaluate the Safety and Efficacy of LY3209590 in Study Participants with Type 1 Diabetes Mellitus Previously Treated with Multiple Daily Injection Therapy

  • Weinstock, Ruth (PI)

Project: Research

Project Details

StatusFinished
Effective start/end date03/17/20 → 03/16/22

Funding

  • Lilly USA LLC: $252,812.00